Literature DB >> 9918343

Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease.

M Merello1, J Balej, M Delfino, A Cammarota, O Betti, R Leiguarda.   

Abstract

OBJECTIVE: To determine the effect of a single dose of apomorphine on internal globus pallidus (GPi) neuronal discharge in patients with Parkinson's disease (PD). PATIENTS AND METHODS: Nine PD patients who underwent microelectrode-guided posteroventral pallidotomy (PVP) were studied. After identification of a single GPi unit discharge with sufficient spike S/N ratio to allow reliable thresholding, basal recording was followed by a single 3-mg subcutaneous injection. One-minute samples were recorded 10', 30', and 60' after apomorphine.
RESULTS: In four patients, recording was lost after 5-10 minutes. In two, changes were observed at peak-of-dose but recording was then lost, whereas three completed recording and returned to baseline, all five showing significant reduction in GPi firing rate (mean +/- standard deviation for basal and post-apomorphine were 143+/-55.6 and 52+/-19.2, respectively; p <0.002).
CONCLUSION: In patients with PD, apomorphine induces changes in GPi spontaneous discharge and modifies firing rates resembling recordings in normal primates. These findings show that clinical improvement as well as induction of dyskinesias following DA administration could be mediated by reduction of GPi outflow.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918343     DOI: 10.1002/1531-8257(199901)14:1<45::aid-mds1009>3.0.co;2-f

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies.

Authors:  Martin Lévesque; André Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

Review 2.  Exendin-4 for Parkinson's disease.

Authors:  Felipe de Jesús Esparza-Salazar; Alma Rosa Lezama-Toledo; Germán Rivera-Monroy; Cesario V Borlongan
Journal:  Brain Circ       Date:  2021-03-30

3.  Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease.

Authors:  P Brown; A Oliviero; P Mazzone; A Insola; P Tonali; V Di Lazzaro
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

4.  Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism.

Authors:  A Raz; E Vaadia; H Bergman
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 5.  Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research.

Authors:  Thomas Wichmann; Hagai Bergman; Mahlon R DeLong
Journal:  J Neural Transm (Vienna)       Date:  2017-06-10       Impact factor: 3.575

6.  Neuronal discharge patterns in the globus pallidus pars interna in a patient with Parkinson's disease and hemiballismus secondary to subthalamotomy.

Authors:  Daniel Cerquetti; José Angel Obeso; Marcelo Merello
Journal:  Exp Brain Res       Date:  2011-07-24       Impact factor: 1.972

7.  Altered discharge pattern of basal ganglia output neurons in an animal model of idiopathic dystonia.

Authors:  Manuela Gernert; Mustapha Bennay; Maren Fedrowitz; Jan H Rehders; Angelika Richter
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

8.  Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.

Authors:  Gali Heimer; Izhar Bar-Gad; Joshua A Goldberg; Hagai Bergman
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.

Authors:  Pedro Barroso-Chinea; Erwan Bezard
Journal:  Front Neuroanat       Date:  2010-09-14       Impact factor: 3.856

10.  µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease.

Authors:  Erwan Bezard; Qin Li; Heather Hulme; Elva Fridjonsdottir; Anna Nilsson; Elsa Pioli; Per E Andren; Alan R Crossman
Journal:  J Neurosci       Date:  2020-07-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.